CVE-2022-45611
Published: 22 August 2023
Summary
CVE-2022-45611 is a critical-severity Insufficiently Protected Credentials (CWE-522) vulnerability in Fresenius-Kabi Pharmahelp Firmware. Its CVSS base score is 9.8 (Critical).
Operationally, ranked at the 42.3th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2022-48475
Vulnerability details
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Training instructs users on protecting credentials from disclosure or unauthorized access.
Training records for security awareness and role-based training verify education on credential protection practices, tangibly reducing risks from mishandling or exposing credentials.
Protecting authenticator content from unauthorized disclosure and modification while requiring protective controls addresses insufficiently protected credentials.
Rules of behavior include credential protection and non-sharing requirements, reducing exposure of insufficiently protected credentials.
Terminating or revoking credentials stops use of insufficiently protected or lingering credentials post-termination.
Requiring confidentiality/integrity protection for stored credentials directly mitigates insufficiently protected credentials on disk or in configuration stores.
Credentials or keys delivered out-of-band are not exposed to interception or inadequate protection on the main transport.